Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP616466.RAeT44q2-6X1FwWKcCW27j6C4xeMRm7OzgCmMPRVs1myI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP616466.RAeT44q2-6X1FwWKcCW27j6C4xeMRm7OzgCmMPRVs1myI130_assertion type Assertion NP616466.RAeT44q2-6X1FwWKcCW27j6C4xeMRm7OzgCmMPRVs1myI130_head.
- NP616466.RAeT44q2-6X1FwWKcCW27j6C4xeMRm7OzgCmMPRVs1myI130_assertion description "[As this is a similar profile to that observed in the CNS from subjects with schizophrenia, we examined whether postmortem CNS tissue from subjects with the disorder and brain striata from an animal model of psychosis or schizophrenia (the amphetamine-sensitized rat) had altered levels of RGS9-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616466.RAeT44q2-6X1FwWKcCW27j6C4xeMRm7OzgCmMPRVs1myI130_provenance.
- NP616466.RAeT44q2-6X1FwWKcCW27j6C4xeMRm7OzgCmMPRVs1myI130_assertion evidence source_evidence_literature NP616466.RAeT44q2-6X1FwWKcCW27j6C4xeMRm7OzgCmMPRVs1myI130_provenance.
- NP616466.RAeT44q2-6X1FwWKcCW27j6C4xeMRm7OzgCmMPRVs1myI130_assertion SIO_000772 17318883 NP616466.RAeT44q2-6X1FwWKcCW27j6C4xeMRm7OzgCmMPRVs1myI130_provenance.
- NP616466.RAeT44q2-6X1FwWKcCW27j6C4xeMRm7OzgCmMPRVs1myI130_assertion wasDerivedFrom befree-20140225 NP616466.RAeT44q2-6X1FwWKcCW27j6C4xeMRm7OzgCmMPRVs1myI130_provenance.
- NP616466.RAeT44q2-6X1FwWKcCW27j6C4xeMRm7OzgCmMPRVs1myI130_assertion wasGeneratedBy ECO_0000203 NP616466.RAeT44q2-6X1FwWKcCW27j6C4xeMRm7OzgCmMPRVs1myI130_provenance.